Literature DB >> 23975559

Predictive ability of C-reactive protein for early mortality after ischemic stroke: comparison with NIHSS score.

Mojdeh Ghabaee1, Ali Zandieh, Shahrzad Mohebbi, Mohammad Fakhri, Homa Sadeghian, Fatemeh Divani, Hamed Amirifard, Mohammadreza Mousavi-Mirkala, Majid Ghaffarpour.   

Abstract

We aimed to compare the association of high-sensitivity C-reactive protein (CRP) and National Institutes of Health Stroke Scale (NIHSS) score with mortality risk and to determine the optimal threshold of CRP for prediction of mortality in ischemic-stroke patients. A series of 162 patients with first-ever ischemic-stroke admitted within 24 h after onset of symptoms was enrolled. CRP and NIHSS score were estimated on admission and their predictive abilities for mortality at 7 days were determined by logistic-regression analyses. Receiver-Operating Characteristic (ROC) curves were depicted to identify the optimal cut-off of CRP, using the maximum Youden-index and the shortest-distance methods. Deceased patients had higher levels of CRP and NIHSS on admission (8.87 ± 7.11 vs. 2.20 ± 4.71 mg/l for CRP, and 17.31 ± 6.36 vs. 8.70 ± 4.85 U for NIHSS, respectively, P < 0.01). CRP and NIHSS were correlated with each other (r (2) = 0.39, P < 0.001) and were also independently associated with increased risk of mortality [odds ratios (95 % confidence interval) of 1.16 (1.05-1.28) and 1.20 (1.07-1.35) for CRP and NIHSS, respectively, P < 0.01]. The areas under the ROC curves of CRP and NIHSS for mortality were 0.82 and 0.84, respectively. The CRP value of 2.2 mg/l was identified as the optimal cut-off value for prediction of mortality within 7 days (sensitivity: 0.81, specificity: 0.80). Thus, CRP as an independent predictor of mortality following ischemic-stroke is comparable with NIHSS and the value of 2.2 mg/l yields the optimum sensitivity and specificity for mortality prediction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23975559     DOI: 10.1007/s13760-013-0238-y

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  5 in total

1.  Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer.

Authors:  Dongwhane Lee; Deok Hee Lee; Dae Chul Suh; Hyuk Sung Kwon; Da-Eun Jeong; Joong-Goo Kim; Ji-Sung Lee; Jong S Kim; Dong-Wha Kang; Sang-Beom Jeon; Eun-Jae Lee; Kyung Chul Noh; Sun U Kwon
Journal:  J Neurol       Date:  2019-06-07       Impact factor: 4.849

2.  Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study.

Authors:  Homa Sadeghian; Rouzbeh Motiei-Langroudi
Journal:  Ann Indian Acad Neurol       Date:  2015 Jan-Mar       Impact factor: 1.383

3.  Impact of Early C-Reactive Protein/Albumin Ratio on Intra-Hospital Mortality Among Patients with Spontaneous Intracerebral Hemorrhage.

Authors:  Michael Bender; Kristin Haferkorn; Michaela Friedrich; Eberhard Uhl; Marco Stein
Journal:  J Clin Med       Date:  2020-04-24       Impact factor: 4.241

4.  C-reactive protein for predicting all-cause mortality in patients with acute ischemic stroke: a meta-analysis.

Authors:  Bo Yu; Ping Yang; Xuebi Xu; Lufei Shao
Journal:  Biosci Rep       Date:  2019-02-19       Impact factor: 3.840

5.  Ability of serum C-reactive protein and white blood cell cout in predicting acute schemic stroke. A short -term follow-up study.

Authors:  Babak Bakhshayesh-Eghbali; Seyed-Ali Roudbary; Seddigheh Basir Jafari; Seyedeh-Parand Nabizadeh; Naghmeh Naderi-Asrami; Reza Sohrabnejad
Journal:  Caspian J Intern Med       Date:  2016
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.